AFAlice dos Santos Nunes Ferreira

Alice dos Santos Nunes Ferreira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alice dos Santos Nunes Ferreira has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neurofunctional Outcomes After Pediatric SARS-CoV-2 Infection and Acute Interferon-Related Gene Expression: An Exploratory Observational Pilot Study

    by Alice dos Santos Nunes Ferreira, Bethania Alves Avelar-Freitas, Marco Antônio Alves Schetino, Iara Cristine Jardim Loyola, Viviane Pires de Sousa, Rosalina Tossige-Gomes, Tamiris Campos Duarte, Jonathan Moreira Lopes, Juliane Duarte Santos, Mariana Aguiar Matos, et al.

    Long-term neurofunctional outcomes after pediatric SARS-CoV-2 infection remain incompletely understood, particularly in relation to acute antiviral immune responses. This exploratory observational pilot study assessed neurofunctional performance approximately six months after infection and its association with acute nasopharyngeal interferon-related gene expression. Sixteen children aged 3–10 years with RT-qPCR-confirmed mild COVID-19 underwent cognitive, gross motor, and functional exercise assessments. Transcript abundance of IFNA2, IFNB1, IFNL2/3, IFI6, and OAS2 was evaluated by qPCR. Five children (31.25%) scored below the age-specific MMSE cutoff, and five of 14 children (35.71%) had below-average TGMD-2 performance. Thirteen completed the ISWT, achieving 53.95 ± 13.55% of the individually predicted distance. IFNB1, IFI6, and OAS2 were detected in all acute-phase samples, whereas IFNA2 and IFNL2/3 were not detected. No statistically significant associations were identified between the detected transcripts and subsequent neurofunctional outcomes. Although the small sample size, absence of pre-infection assessments, and lack of an uninfected comparison group limit interpretation of the findings, this pilot study provides preliminary descriptive data integrating acute mucosal interferon-related gene expression with subsequent neurofunctional assessments in children, supporting further investigation in larger, controlled cohorts.

  • Open Access

    One Health Surveillance for SARS-CoV-2 in Non-Human Primates and Small Mammals in Minas Gerais, Brazil

    by Pedro Augusto Almeida-Souza, Thamires Gabriele Macedo Silva, Gabriele Barbosa Penha, Thaynara de Jesus Teixeira, Ramon Oliveira-Silva, Iago Alves Celestino, Maria Eduarda Gonçalves-Dos-Santos, Cirilo Henrique de Oliveira, Alice dos Santos Nunes Ferreira, Emerson Márcio Gusmão, et al.

    Although the SARS-CoV-2 pandemic primarily affected the human population, the virus has also been detected in various animal species worldwide, raising concerns about its potential to establish new animal reservoirs. This study aimed to investigate the presence of SARS-CoV-2 in non-human primates (NHPs) and synanthropic small mammals (SSMs) in the Jequitinhonha Valley and Northern Minas Gerais, Brazil. Between October 2021 and October 2023, 119 animals were sampled, 82 NHPs and 37 SSMs, across 22 municipalities. A total of 342 biological samples—including oral and nasal swabs, lungs, livers, spleens, blood, and feces—were collected and analyzed using RT-qPCR, while 37 serum samples were submitted to neutralization tests. Despite the diversity of sampled species, habitats, and biological materials, no evidence of SARS-CoV-2 infection or specific antibodies was detected in any of the individuals tested. The results suggest that NHPs and SSMs in these regions did not act as reservoirs for SARS-CoV-2 during the study period. This finding is particularly relevant given the high synanthropy of species such as Callithrix penicillata (black-tufted marmoset) and Rattus rattus (black rat), which frequently interact with human populations. Our study underscores the importance of integrating animal, human, and environmental health perspectives under a One Health framework to monitor emerging zoonotic threats. By providing baseline data on SARS-CoV-2 dynamics in wildlife, we emphasize the need for ongoing ecological and epidemiological surveillance to assess potential spillover events and their implications for biodiversity and public health in Brazil.